BACKBEAT Trial)
Brief description of study
Investigational Atrioventricular Interval Modulation (AVIM) software will be loaded onto commercially available Pacemakers (PPM), such as the Medtronic Azure/Astra devices. Therefore, the Azure/Astra devices will be considered investigational while the AVIM is present. AVIM therapy is indicated for the reduction of blood pressure in patients with dual PPM and uncontrolled hypertension despite use of antihypertensives medications.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
